Possible rifampicin-induced arthritis in a patient receiving anti-tuberculosis therapy: the first reported case
Open Access
- 11 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 63 (12) , e331-e332
Abstract
Dear Editor, R, a 76-year-old male undergoing treatment for pulmonary tuberculosis (TB), was referred to rheumatology by the infectious diseases team with suspected gout secondary to anti-tuberculous therapy. He was diagnosed with polymyalgia rheumatica (PMR) 6 years previously but was lost to follow-up and remained on long term low-dose prednisolone of varying doses. He also had prostate cancer with bony metastases; docetaxel chemotherapy was discontinued 9 months previously after only two cycles. Two days after starting rifampicin, isoniazid and pyrazinamide, R reported pain in multiple small and large joints, which was different in location and more severe to that experienced with his PMR. Prior to referral to us, R’s prednisolone had been increased from 6 mg/day to 15 mg/day but provided little relief. Physical examination revealed swelling over his metacarpophalangeal joints (MCPJ), metatarsophalangeal joints, the left wrist and ankle. Laboratory tests were negative for CCP, RF and ANA antibodies. CRP (25 mg/l) and ESR (59 mm/H) were elevated, with a leucocytosis (neutrophils 12.8 × 109/l, white cell count 14.6 × 109/l) possibly due to prednisolone use. Reduced albumin and haemoglobin were considered secondary to cancer and TB. Elevated serum urate (694 μmol/l) raised the suspicion of pyrazinamide-induced gout and pyrazinamide was ceased. R was discharged on a tapering dose of 20 mg prednisolone in addition to colchicine 500 μg tds. Ten days later, upon review by the rheumatology team, he was reporting ongoing significant pain in his hands, feet and knees alongside milder pain in the neck, right shoulder, groin and lower back despite normalization of serum urate (315 μmol/l). There was no reported improvement of symptoms since pyrazinamide cessation, with no previous history of gout. On examination, joint mobility was severely restricted due to pain. There was marked pitting oedema noted over the dorsum of both hands, MCPJ and ankles. An ultrasound (US) demonstrated low-level grey scale joint synovial thickening with increased power Doppler signal in his wrists and MCPJ ( Fig. 1) with similar changes seen around the deep flexor tendon sheaths of the wrist. Marked subcutaneous oedema was also noted over the dorsum of both hands and ankles. There was evidence of calcium pyrophosphate deposition (CPPD) bilaterally in the knee medial menisci but no specific features of gout or rheumatoid arthritis (RA); double contour, tophi or erosions were absent.Keywords
This publication has 7 references indexed in Scilit:
- A prospective study of docetaxel-associated pain syndromeSupportive Care in Cancer, 2017
- Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis StudyClinical Infectious Diseases, 2015
- ‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvantsJournal of Autoimmunity, 2011
- Hyperuricemia and Arthralgias During Pyrazinamide Therapy in Patients With Pulmonary TuberculosisLaboratory Medicine, 2007
- Rifamycin-induced lupus syndromeThe Lancet, 1997
- Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases?1997
- Adverse reactions to rifampicin in antituberculosis regimensJournal of Antimicrobial Chemotherapy, 1977